PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS

Clinical trials for PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS trials appear

Sign up with your email to follow new studies for PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cancer drug duo enters human testing

Disease control Recruiting now

This study is testing a new combination of two drugs, SHR-1501 and adbelizumab, for people with advanced or metastatic cancers that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see if the combination can shri…

Matched conditions: PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 06, 2026 15:38 UTC

PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS

Get alerted when new PATIENTS WITH ADVANCED OR METASTATIC MALIGNANT TUMORS trials appear

New cancer drug duo enters human testing